A case decades in the making: Barron vs. Tour
Monday, November 16, 2009
1987 – As an 18-year-old freshman at LSU, Barron is diagnosed with mitral valve prolapse and is prescribed medication commonly known as a beta blocker.
1995 – Plays in 21 events on the Nationwide Tour, making 11 cuts and finishing 103rd on the money list, with $14,773.
December 1995 – Misses the cut in the final stage of Q-School.
June 1996 – Plays in the FedEx St. Jude Classic, his first PGA Tour event as a professional, and misses the cut.
1996 – Earns $43,433 to finish 47th on the Nationwide Tour money list.
December 1996 – Qualifies for the PGA Tour, finishing third in Q-School.
1997 – Keeps his Tour card by finishing 116th on the money list, with $198,051.
1998-2000 – Keeps his card, ranking 108-123 on the money list.
2001 – Loses his card and fails to regain it at Q-School, finishing T-37th.
2002 – Plays his way back onto Tour, placing third on Nationwide money list, with $248,175.
2003 – It’s back to Q-School after a 167th-place finish, with $224,589.
December 2003 – Misses card with a T-155th at Q-School.
2004 – Finishes 29th on Nationwide money list, with $175,591.
December 2004 – A T-26th in Q-School merits his card.
May 2005 – Posts highest finish in a Tour event, T-3 at the EDS Byron Nelson Championship.
Fall 2005 – Diagnosed with low testosterone and is prescribed monthly doses of exogenous testosterone; misses the last four cuts of the year.
2005 – Keeps his card, ranking 110th with $731,990.
2006 – Surrenders card by earning $388,226 to rank 164th.
June 23 or 28*, 2008 – Applies for TUEs for the beta blocker Propranolol and exogenous testosterone. (* The Tour and Barron have different dates for the application.)
July 3, 2008 – Tour enacts anti-doping policy, with both of Barron’s medications on the banned list.
October 2008 – Stops taking monthly does of exogenous testosterone.
Oct 10, 2008 – Tour denies the TUE for Propranolol; Barron appeals.
Oct. 22, 2008 – Commissioner Tim Finchem denies appeal and instructs Barron to begin weaning himself off the drug.
2008 – Barron earns only $33,446 in 17 events on the Nationwide Tour.
Jan. 20 or 21*, 2009 – Tour denies the TUE for exogenous testosterone and instructs Barron to stop taking the drug. (* The Tour and Barron have different dates for the decision.)
Spring – Barron starts to take Lyrica as a substitute for Propranolol.
Early June – A doctor injects Barron with exogenous testosterone.
June 11 – Barron is drug-tested at the St. Jude Classic.
June 15 – Barron misses the cut at St. Jude.
2009 – Barron’s sample is found to contain Propranolol and testosterone.
July 23, Aug. 12 – Barron provides additional information to the Tour about his use of Propranolol and testosterone.
Oct. 20 – The Tour suspends Barron for one year (until Sept. 20, 2010) for violating the anti-doping ban on performance-enhancing drugs.
Nov. 12 – Barron files suit in the Chancery Court of Tennessee for monetary damages and injunctive relief.
Nov. 12 – Tour requests the case be moved to the U.S. District Court in the Western District of Tennessee.
Nov. 13 – Barron vs. PGA Tour is heard.
Nov. 16 – U.S. Magistrate Judge Tu Pham denies Barron’s request for a temporary restraining order against the Tour.
Golfweek.com readers: We value your input and welcome your comments, but please be respectful in this forum.